Surgery
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
August 11, 2011 3:47 am | by Bio-Medicine.Org | News | CommentsPARSIPPANY, N.J., Aug. 11, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced financial results for the second quarter ended June 30, 2011, provided an update on the execution of its pre-commercial and launch strategies for...
Cook Medical's Doppler Blood Flow Monitor a Significant Advance for Free Flap Procedures
August 10, 2011 10:47 am | News | CommentsTechnology leverages company's patented Doppler platform, providing surgeons with a direct vessel monitoring tool to assist in transplant and reconstructive surgeries
Patent Granted for Simbionix Procedure Rehearsal Studioâ„¢
August 10, 2011 7:45 am | by Bio-Medicine.Org | News | CommentsCLEVELAND, Ohio, August 10, 2011 /- Simbionix USA Corporation, the world's leading provider of medical simulation training and education products for medical professionals and the healthcare industry, is pleased to announce it has been granted a patent in the UK for its innovative...
Misonix Announces Entry Into Surgical Wound Debridement
August 10, 2011 7:45 am | by Bio-Medicine.Org | News | CommentsFARMINGDALE, N.Y., Aug. 10, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...
United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
August 9, 2011 4:43 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others...
MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device
August 9, 2011 4:43 am | by Bio-Medicine.Org | News | CommentsATLANTA, Aug. 9, 2011 /- MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced its new DynaNail™ Intramedullary Ankle Fusion Nail. Ankle fusion is performed to relieve pain in patients with severely degenerative ankle joints, to...
David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
August 5, 2011 9:48 am | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif., Aug. 5, 2011 /- Varian Medical Systems, Inc. (NYSE: VAR ) today announced that David J. Illingworth, a former CEO and member of the Board of Directors for Smith & Nephew and veteran of more than 30 years of management in global medical device businesses, has been...
Misonix Announces Update of Product Registration in Brazil
August 5, 2011 5:41 am | by Bio-Medicine.Org | News | CommentsFARMINGDALE, N.Y., Aug. 5, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...
Precision Optics lands $2.5M in patent sale
August 4, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | News | CommentsPrecision Optics Corp. Inc., a maker of advanced optical instruments in Gardner, has formed a deal with Intuitive Surgical Operations Inc., a surgical robotics firm in California, bringing $2.5 million to Precision Optics.
Hanger Orthopedic Group Announces Five Acquisitions Producing $20.2 million of Annual Net Revenue
August 3, 2011 6:42 am | by Bio-Medicine.Org | News | CommentsAUSTIN, Texas, Aug. 3, 2011 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) is pleased to announce the acquisition of Team Post-Op, Inc., BioConcepts, Inc., US Orthotics & Prosthetics, Inc., MK Prosthetic & Orthotic Services, Inc, and Rainier Surgical Incorporated &...
Misonix Announces New Distribution Agreement for Taiwan
August 3, 2011 6:42 am | by Bio-Medicine.Org | News | CommentsFARMINGDALE, N.Y., Aug. 3, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...
Cantel Medical Acquires Byrne Medical, Inc., Substantially Increasing Its Presence in GI Endoscopy
August 2, 2011 6:48 am | by Bio-Medicine.Org | News | CommentsLITTLE FALLS, N.J., Aug. 2, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ), through its Minntech subsidiary, has acquired the business and substantially all of the assets of Byrne Medical, Inc. Byrne Medical, privately-owned and based outside Houston, TX, designs, manufactures and sells...
MedSolutions Introduces Spine Surgery Management Program
July 21, 2011 9:48 am | by Bio-Medicine.Org | News | CommentsFRANKLIN, Tenn., July 21, 2011 /- MedSolutions , a leading provider of medical management services, today announced the launch of its Lumbar Spine Surgery Management Program for ensuring the clinical appropriateness of spine surgery for individuals suffering from lower back pain, spinal...
Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESSâ„¢ 30 Surgical Cutting and Stapling Device
July 19, 2011 10:39 am | by Bio-Medicine.Org | News | CommentsREDWOOD CITY, Calif., July 19, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that Andreas Kuthe, M.D., Chief of General Surgery at the Red Cross Hospital Clementinenhaus, Hannover, Germany, successfully completed a total of five laparoscopic procedures using Cardica's' proprietary...
Kuros Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing
July 19, 2011 1:42 am | by Bio-Medicine.Org | News | CommentsZURICH, July 19, 2011 /- Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has received Notice of Allowance for U.S....
Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
July 18, 2011 4:43 am | by Bio-Medicine.Org | News | CommentsPHILADELPHIA, July 18, 2011 /- Shire plc (LSE: SHP; NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Tablets for the maintenance of remission in patients...
Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
July 18, 2011 4:43 am | by Bio-Medicine.Org | News | CommentsPHILADELPHIA, July 18, 2011 /- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda ® (mesalamine) Delayed Release Tablets for the maintenance of remission in...
Hologic to Participate in Four Investor Conferences
July 14, 2011 7:34 am | by Bio-Medicine.Org | News | CommentsBEDFORD, Mass., July 14, 2011 /- Hologic, Inc. (NASDAQ: HOLX ) today announced that company management will participate in the following conferences: Deborah Gordon, Vice President, Investor Relations, will host investor meetings at the Lazard Capital Markets Corporate Access Day in...
FDA: Surgical Placement of Mesh to Repair Pelvic Organ Prolapse Poses Risks
July 13, 2011 10:36 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., July 13, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients...
Stryker Ends Distribution Agreement With Corin PLC
July 13, 2011 7:37 am | by Bio-Medicine.Org | News | CommentsMAHWAH, N.J., July 13, 2011 /- Stryker Corporation's Orthopaedics division has reached a mutual agreement with Corin PLC in which Corin will resume direct distribution of the Cormet Hip Resurfacing System. Stryker will no longer act as a distributor of the product. "Distribution of a hip...
MarketsandMarkets: Lung Cancer Surgery Market (Devices & Treatment Outlook) to be US$ 46.5 Billion by 2015
June 30, 2011 8:36 am | by Bio-Medicine.Org | News | CommentsDALLAS, Texas, June 30, 2011 /- The ' Lung Cancer Surgery Market (Devices & Treatment Outlook) - Trends & Challenges (2010 - 2015) " analyzes the lung cancer market by types of surgical procedures and surgical devices and studies the market dynamics of North America, Europe and...
Boston Scientific Welcomes Publication of Landmark Report on Chronic Pain
June 30, 2011 8:36 am | by Boston Scientific | News | CommentsNATICK, Mass., June 30, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of Sciences titled Relieving
Ovarian Cancer Genome Mapped, Opens Door to Personalized Medicine
June 29, 2011 9:36 am | by Lawrence Berkeley National Laboratory | News | CommentsScientists have developed the first comprehensive catalog of the genetic aberrations responsible for an aggressive type of ovarian cancer that accounts for 70 percent of all ovarian cancer deaths. Hundreds of researchers from more than 80 institutions, including scientists from Berkeley...
Ascension Orthopedics Implants PyroTITANâ„¢ in Geelong, Australia
June 29, 2011 9:36 am | by Bio-Medicine.Org | News | CommentsAUSTIN, Texas, June 29, 2011 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard S. Page, MB.BS.FRACS(ORTH) at St. John of God Hospital. "The...
Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
June 27, 2011 3:35 am | by Bio-Medicine.Org | News | CommentsPARSIPPANY, N.J., June 27, 2011 /- Pacira Pharmaceuticals, Inc ., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that it has been included in the Russell 3000® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and...
